Dr. Michael Mack

Dr. Michael J. Mack is an internationally renowned cardiothoracic surgeon who has made significant contributions to research involving novel minimally invasive surgery and valvular heart disease therapies. Michael has been in practice since 1982 and has performed thousands of cardiac surgeries, of which well over 4,000 have involved heart valve procedures.

Dr. Mack has spent much of his career working closely with interventional cardiologists to improve the treatment of patients with cardiovascular disease. He played critical roles in the SYNTAX Trial, which compared percutaneous coronary intervention with coronary artery bypass graft surgery in patients with three-vessel or left main disease, and the PARTNER Trial, which explored the safety and efficacy of transcatheter aortic valve replacement. He has also authored or co-authored over 400 publications in peer-reviewed journals.

Dr. Mack is currently the Director of the Cardiovascular Service line at Baylor Scott & White Health System and Chairman of the Baylor Plano Research Center in Texas. Previously, he served as Medical Director Cardiovascular Disease and Transplantation at Medical City Dallas Hospital. Dr. Mack was President of the Society for Thoracic Surgeons (STS) in 2011 and a Past President of the Thoracic Surgery Foundation for Research and Education (TSFRE), the Southern Thoracic Surgical Association (STSA), and the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). He is a member of the American College of Cardiology Foundation (ACCF) Board of Trustees and the ACC Interventional Scientific Council. He received his medical degree from St. Louis University in Missouri.